Article Details

AstraZeneca cancer R&D exec Charles Ferté hits the exit

Retrieved on: 2021-04-21 08:03:45

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca cancer R&D exec Charles Ferté hits the exit. View article details on hiswai:

Excerpt

Charles Ferté, M.D., Ph.D., the senior director, global project leader of oncology R&D at AstraZeneca is leaving the company. In a Twitter post, Ferté ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up